HAPPHY trial: primary prevention against coronary heart disease with beta-blockers ruled out by HAPPHY?
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D001581:Benzothiadiazines; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000517:prevention & control*; D004232:Diuretics; D006801:Humans; D008297:Male; D008875:Middle Aged; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors